How big is the Global Central Nervous System Biomarkers Market?

The Global Central Nervous System Biomarkers Market size is expected to reach USD 5.61 billion in 2024 and grow at a CAGR of 7.67% to reach USD 8.12 billion by 2029. Read More

What is the current Global Central Nervous System Biomarkers Market size?

In 2024, the Global Central Nervous System Biomarkers Market size is expected to reach USD 5.61 billion. Read More

Who are the key players in Global Central Nervous System Biomarkers Market?

G-Biosciences, Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc. and Biomeriux (Banyan Biomarkers Inc.) are the major companies operating in the Global Central Nervous System Biomarkers Market. Read More

Which is the fastest growing region in Global Central Nervous System Biomarkers Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Central Nervous System Biomarkers Market?

In 2024, the North America accounts for the largest market share in Global Central Nervous System Biomarkers Market. Read More

What years does this Global Central Nervous System Biomarkers Market cover, and what was the market size in 2023?

In 2023, the Global Central Nervous System Biomarkers Market size was estimated at USD 5.21 billion. The report covers the Global Central Nervous System Biomarkers Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Central Nervous System Biomarkers Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Central Nervous System Biomarkers Market

Central Nervous System Biomarkers Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Global Central Nervous System Biomarkers Market Forecast and it is Segmented by Type of CNS Biomarkers (Safety Biomarker, Efficacy Biomarker, Validation Biomarker, and Other Types of CNS Biomarkers), Application (Drug Discovery and Development, Personalized Medicine, and Other Applications), End User (Diagnostic Labs, Clinics/Hospitals, and Research Centers), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market values are provided in terms of (USD million) for the above segments.

Central Nervous System Biomarkers Industry Overview

The global players in the central nervous system biomarkers market include Acumen Pharmaceuticals Inc., Alseres Pharmaceuticals Inc., Aposense Ltd, Avacta Life Sciences Limited, Banyan Biomarkers Inc., Bio-Rad Laboratories Inc., DiaGenic ASA, G-Biosciences, Merck KGaA, and Thermo Fisher Scientific Inc. The players strategically invest in the research and development for innovative and technological advancements and focus on partnerships with domestic players to expand their outreach.